Rituximab as Adjunct Maintenance Therapy for Refractory Juvenile Myasthenia Gravis

The objective of our study was to assess the tolerability and efficacy of rituximab use in children with refractory JMG.

Source: Pediatric Neurology - July 5, 2020 Category: Neurology Authors: Carla D. Zingariello, Melissa E. Elder, Peter B. Kang Tags: Short Communication Source Type: research